Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

SpO2 Validation Study-Philips Optimus

NCT: NCT07215429 · TERMINATED

NCT IDNCT07215429
StatusTERMINATED
Start Date2025-09-09
Completion2025-09-19

Brief Summary

Validation study to validate the SpO2 accuracy performance of the Sponsor's SpO2 sensors over the range of 70-100% SaO2 during non-motion conditions assessed by CO-Oximetry

Frequently Asked Questions

What is SpO2 Validation Study-Philips Optimus?

SpO2 Validation Study-Philips Optimus is a clinical trial registered under NCT07215429. Current status: TERMINATED.

What is the status of NCT07215429?

The current status of NCT07215429 (SpO2 Validation Study-Philips Optimus) is: TERMINATED.

When did SpO2 Validation Study-Philips Optimus start?

SpO2 Validation Study-Philips Optimus started on 2025-09-09.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑